Trademarkia Logo

Australia

AU$
MS PLUS HEALTHY AGEING
Registered: Registered/protected

Last updated on 11 Nov 2024

Owner Info

Multiple Sclerosis Australia

Level 19, 100 Miller Street

North Sydney, NSW, 2060 AUSTRALIA,

Serial Number

2439724 filed on 2 Apr 2024

Correspondent

HopgoodGanim

Level 8 Waterfront Place,

1 Eagle Street,

BRISBANE, QLD, 4000 AUSTRALIA

MS PLUS HEALTHY AGEING

Classification Information


Class [009]
Computer software; Programs (recorded); Computer software applications (downloadable); Downloadable software applications (apps); Electromagnetic medi Read More

Class [036]
Financial services; Charitable collections; Charitable fundraising; Charitable services, namely financial services; Financial sponsorship; Monetary af Read More

Class [041]
Education services; Training; Entertainment; Cultural activities; Sporting activities; Providing information, including online, about education, train Read More

Class [042]
Provision of online non-downloadable software (application service provider); Provision of online non-downloadable web-based software; Software as a s Read More

Class [044]
Medical services; Health care; Nursing care; Psychiatry; Provision of medical information; Providing information including online, about medical servi Read More

Class [045]
Personal care services (non-medical caregiving services); Personal care services (non-medical for disabled persons); Personal care services (non-medic Read More

Mark Details


Serial Number

2439724

Registered On

2 Apr 2024

Renewal On

2 Apr 2034

Mark Type

FIGURATIVE

Legal History


Show more

Status DateAction Taken
11th Nov 2024IP Right Registered correspondence sent
11th Nov 2024IP Right Registration Published
11th Nov 2024Status change to Registered/Protected
3rd Sept 2024Application Accepted correspondence sent
3rd Sept 2024IP Right has been Examined
3rd Sept 2024IP Right Acceptance Published
6th May 2024Early Acceptance Notice correspondence sent
6th May 2024Status change to Accepted
3rd May 2024Examination Response Received
12th Apr 2024Adverse Report (Examination) correspondence sent